Rahbar S - Search Results

1

A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.

Bhatwadekar A, Glenn JV, Figarola JL, Scott S, Gardiner TA, Rahbar S, Stitt AW. Bhatwadekar A, et al. Among authors: rahbar s. Br J Ophthalmol. 2008 Apr;92(4):545-7. doi: 10.1136/bjo.2007.127910. Epub 2008 Jan 22. Br J Ophthalmol. 2008. PMID: 18211931

2

Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.

Satheesan S, Figarola JL, Dabbs T, Rahbar S, Ermel R. Satheesan S, et al. Among authors: rahbar s. Br J Pharmacol. 2014 Jun;171(12):3103-14. doi: 10.1111/bph.12656. Br J Pharmacol. 2014. PMID: 24611770 Free PMC article.

3

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S. Figarola JL, et al. Among authors: rahbar s. Diabetologia. 2003 Aug;46(8):1140-52. doi: 10.1007/s00125-003-1162-0. Epub 2003 Jul 5. Diabetologia. 2003. PMID: 12845431

4

LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.

Figarola JL, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S. Figarola JL, et al. Among authors: rahbar s. Diabetologia. 2008 May;51(5):882-91. doi: 10.1007/s00125-008-0935-x. Epub 2008 Mar 4. Diabetologia. 2008. PMID: 18317729

5

Proinflammatory effects of advanced lipoxidation end products in monocytes.

Shanmugam N, Figarola JL, Li Y, Swiderski PM, Rahbar S, Natarajan R. Shanmugam N, et al. Among authors: rahbar s. Diabetes. 2008 Apr;57(4):879-88. doi: 10.2337/db07-1204. Epub 2007 Nov 14. Diabetes. 2008. PMID: 18003754 Free PMC article.

6

Novel inhibitors of advanced glycation endproducts.

Rahbar S, Kumar Yernini K, Scott S, Gonzales N, Lalezari I. Rahbar S, et al. Biochem Biophys Res Commun. 1999 Sep 7;262(3):651-6. doi: 10.1006/bbrc.1999.1275. Biochem Biophys Res Commun. 1999. PMID: 10471380

7

Novel inhibitors of advanced glycation endproducts (part II).

Rahbar S, Yerneni KK, Scott S, Gonzales N, Lalezari I. Rahbar S, et al. Mol Cell Biol Res Commun. 2000 Jun;3(6):360-6. doi: 10.1006/mcbr.2000.0239. Mol Cell Biol Res Commun. 2000. PMID: 11032758

8

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation.

Rahbar S, Natarajan R, Yerneni K, Scott S, Gonzales N, Nadler JL. Rahbar S, et al. Clin Chim Acta. 2000 Nov;301(1-2):65-77. doi: 10.1016/s0009-8981(00)00327-2. Clin Chim Acta. 2000. PMID: 11020463

9

LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein.

Lalezari I, Rahbar S, Lalezari P, Fermi G, Perutz MF. Lalezari I, et al. Among authors: rahbar s. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6117-21. doi: 10.1073/pnas.85.16.6117. Proc Natl Acad Sci U S A. 1988. PMID: 3413080 Free PMC article.

10

A new rapid method to detect inhibition of Amadori product generated by delta-gluconolactone.

Rahbar S, Nadler JL. Rahbar S, et al. Clin Chim Acta. 1999 Sep;287(1-2):123-30. doi: 10.1016/s0009-8981(99)00125-4. Clin Chim Acta. 1999. PMID: 10509901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters